Cannabis company MGC Pharmaceuticals on watch after "transformational event"

The MGC Pharmaceuticals Ltd (ASX:MXC) share price could be on the rise on Friday after a late announcement by the cannabis company…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price could be on the move today after the cannabis company released a late announcement on Thursday.

What did MGC Pharmaceuticals announce?

On Thursday MGC Pharmaceuticals provided an update on the planned construction of its Malta-based state-of-the-art Good Manufacturing Practice (GMP) production and research facility.

According to the release, the company has signed a long-term lease agreement on a 6,000m2 site in Malta, which was previously identified and designated to MGC Pharma by Malta Industrial Parks.

The lease agreement was signed following formal approval from Malta Enterprise as part of a government signing ceremony held in Malta on Thursday.

What now?

Management believes this represents a major event for the Maltese medical cannabis industry, as the company's facility will be one of the first commercial EU-GMP grade production and research facilities in the country within the medical cannabis sector.

It will also facilitate development of expertise for cannabinoid derived medicines and research in Malta with subsequent products to be delivered into the European Union and global markets.

MGC Pharma's co-founder and managing director, Roby Zomer, described this as a transformational event and one which provides a gateway to key European and global markets.

He said: "The Maltese facility, when constructed, will be our centralised European production and distribution hub. This will be integral as we advance our strategy of becoming a leading European focused producer of cannabinoid derived medicinal products. The Maltese facility will significantly scale up our existing operations and commercial activities currently based in Slovenia and the Czech Republic."

He added: "The lease agreement is a key step forward, and with planning approvals also in place we will now look to swiftly move into the construction phase. The state-of-the-art Maltese facility is to be a key asset for MGC Pharma to provide a platform for future product development and commercial growth, with large-scale production driving strong future revenues upon completion. I look forward to updating shareholders with details of our progress in the upcoming months."

It has been another busy week for the cannabis industry. This week Elixinol Global Ltd (ASX: EXL) announced a supply agreement with Pet Releaf, Creso Pharma Ltd (ASX: CPH) revealed an exclusive distribution agreement with Medleaf Therapeutics, and Althea Group Holdings Ltd (ASX: AGH) provided a positive update on the number of patients being prescribed its medicinal cannabis in Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Person handing out $50 notes, symbolising ex-dividend date.
Broker Notes

Where to invest $20,000 into ASX 200 shares

Brokers think these shares could be top picks for Aussie investors.

Read more »

The words short selling in red against a black background
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Woman in celebratory fist move looking at phone
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A female financial services professional with a manicured black afro hairstyle turns an ipad screen to show a client across the table a set of ASX shares figures in graph format.
Share Market News

Record CBA share price and blockbuster merger push ASX 200 financials sector to the top

ASX financial stocks led the 11 market sectors last week with a 1.95% gain.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Share Market News

CBA Shares in focus: How Australia's most valuable company is using AI to compete

Could AI initiatives drive CBA shares higher?

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Broker Notes

These ASX 200 shares could rise 20% to 50%

Looking for big returns? Brokers think these shares could do the job.

Read more »

asx share price represented by cartoon letters spelling the word FOMO
Share Market News

What did Macquarie's "FOMO Meter" reveal about the stock market in May?

Is the market getting frothy or is there still room to climb?

Read more »

Market up or down
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the week...

Read more »